Low-Dose Interleukin-2 and HCV-Induced Vasculitis

被引：0
|
作者：
Oo, Ye Htun [1 ]
Mutimer, David [1 ]
Adams, David H. [1 ]
机构：
[1] Liver Res Ctr, Birmingham, W Midlands, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 14期
基金：
英国医学研究理事会;
关键词：
TOLERANCE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1353 / 1354
页数：2
相关论文
共 50 条
  • [1] Low-Dose Interleukin-2 and HCV-Induced Vasculitis REPLY
    Saadoun, David
    Cacoub, Patrice
    Klatzmann, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14): : 1354 - 1354
  • [2] Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
    Saadoun, David
    Rosenzwajg, Michelle
    Joly, Florence
    Six, Adrien
    Carrat, Fabrice
    Thibault, Vincent
    Sene, Damien
    Cacoub, Patrice
    Klatzmann, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (22): : 2067 - 2077
  • [3] Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis (vol 365, pg 2067, 2011)
    Saadoun, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (08): : 786 - 786
  • [4] Diabetes mellitus induced by low-dose interleukin-2
    Soni, N
    Meropol, NJ
    Porter, M
    Caligiuri, MA
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (01) : 59 - 62
  • [5] LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTERLEUKIN-2 FOR MALIGNANT-MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    DEAN, G
    MOORE, J
    BRADLEY, EC
    [J]. BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1989, 65 (01) : 128 - 144
  • [6] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
  • [7] Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis
    Lim, Tiong Y.
    Martinez-Llordella, Marc
    Kodela, Elisavet
    Gray, Elisabeth
    Heneghan, Michael A.
    Sanchez-Fueyo, Alberto
    [J]. HEPATOLOGY, 2018, 68 (04) : 1649 - 1652
  • [8] Low-dose interleukin-2 for systemic lupus erythematosus?
    Wallace, Daniel J.
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (01): : E7 - E8
  • [9] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon - Reply
    McDermott, DF
    Regan, MM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6268 - 6269
  • [10] EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    BRADLEY, EC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) : 409 - 424
12345